Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-12-053032
Filing Date
2012-12-28
Accepted
2012-12-28 16:41:36
Documents
2
Period of Report
2012-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3665
2 MISCELLANEOUS EXHIBITS misc1.htm EX-99.1 7584
  Complete submission text file 0001140361-12-053032.txt   13527
Mailing Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000
Business Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000 35317094000
ELAN CORP PLC (Reporting) CIK: 0000737572 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35676 | Film No.: 121291365
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 353 1 709 4700
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN L2 DUBLIN 2
Business Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN L2 DUBLIN 2 353 1 709 4000
Elan Science One Ltd (Reporting) CIK: 0001565579 (see all company filings)

State of Incorp.: L2 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35676 | Film No.: 121291364